刘新泳山东大学主页平台管理系统--中文主页

论文成果

[31] 张硕. Efficient drug discovery by rational lead hybridization based on crystallographic overlay. Drug Discovery Today, 24, 805, 2019.
[32] 康东伟. Discovery and Characterization of Fluorine-Substituted Diarylpyrimidine Derivatives as Novel HIV-.... 《Journal of Medicinal Chemistry》, 63, 1298, 2020.
[33] 康东伟. Structure-Based Bioisosterism Yields HIV-1 NNRTIs with Improved Drug-Resistance Profiles and Favo.... 《Journal of Medicinal Chemistry》, 63, 4837, 2020.
[34] 康东伟. In situ click chemistry-based rapid discovery of novel HIV-1 NNRTIs by exploiting the hydrophobic.... EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 193, 2020.
[35] 康东伟. Exploring the hydrophobic channel of NNIBP leads to the discovery of novel piperidine-substituted.... ACTA PHARMACEUTICA SINICA B, 10, 878, 2020.
[36] 杨斐. Chiral Metal Nanoparticle Superlattices Enabled by Porphyrin-Based Supramolecular Structures. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2021.
[37] 康东伟. 2,4,5-Trisubstituted Pyrimidines as Potent HIV-1 NNRTIs: Rational Design, Synthesis, Activity Eva.... 《Journal of Medicinal Chemistry》, 64, 4239, 2021.
[38] 封达. Design, synthesis, and evaluation of "dual-site"-binding diarylpyrimidines targeting both NNIBP a.... EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 211, 2021.
[39] 汪昭. Targeting dual tolerant regions of binding pocket: Discovery of novel morpholine-substituted diar.... EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 206, 2020.
[40] 康东伟. Structure-Activity Relationship Exploration of NNIBP Tolerant Region I Leads to Potent HIV-1 NNRT.... ACS INFECTIOUS DISEASES, 6, 2225, 2020.

共558条 4/56

首页上页下页尾页页

刘新泳

教授

性别：男

在职信息：在职

所在单位：药学院

入职时间： 1991-07-01

版权所有 ©山东大学　地址：中国山东省济南市山大南路27号　邮编：250100　
查号台：（86）-0531-88395114
值班电话：（86）-0531-88364731　建设维护：山东大学信息化工作办公室　　
访问量：手机版 English 登录山东大学

最后更新时间： ..